Dr Michael J. Grey
University of East Anglia
Michael Grey is a neuroscientist specialising in neuroplasticity and neurorehabilitation following acquired brain injury. He is investigating novel uses of virtual reality technology for neurorehabilitation and uses non-invasive electrophysiology, brain stimulation and neuroimaging techniques to study neuroplasticity.
Dr Grey works with the Acquired Brain Injury Rehabilitation Alliance and the NIHR Brain Injury MedTech Co-operative. At the University of East Anglia, Dr Grey leads research investigating the use of virtual reality for assessment of sport concussion and acquired brain injury rehabilitation.
Effecting neuroplasticity with virtual rehabilitation
Virtual Reality (VR) applications are available across the rehabilitation spectrum, with tools ranging from simple smartphone apps to fully immersive virtual environments with robotic interfaces. There are great opportunities – and increasing competition – for the use of VR in neurorehabilitation. However, effective neurorehabilitation requires neuroplasticity. In this talk, I will argue the best VR technology for neurorehabilitation is implemented with the principles of neuroplasticity firmly in mind.
EVEN MORE SEMINARS
Professor Gus A Baker Tribune Neuropsychology Services, University of Liverpool, Walton Centre for Neurology& Neurosurgery
The additional burden of epilepsy: a psychological and neuropsychological perspective
Rosanne Tyas Royal Hospital for Neuro-disability
Emotional Support and Adaption: Considering emotional aspects of music therapy with people with a neuro-disability.
Dr Nicholas Silver The Walton Centre for Neurology and Neurosurgery, Liverpool; The Brain Charity
More than just a headache, more than just prescribing drugs
Martin Knight MD FRCS MBBS The Spinal Foundation
Indications and long-term outcomes for Transforaminal Endoscopic Lumbar Decompression and Foraminoplasty (TELDF)
Khashayar Pazooki Groupe Psylux S.A. / Neuroacademy Luxembourg
QEEG /ERP & psychometry into an individualized & personalized medicinal treatment Model of psychiatric disorders